220 related articles for article (PubMed ID: 7689446)
21. Mechanisms of clinical resistance to fluoroquinolones in Staphylococcus aureus.
Nakanishi N; Yoshida S; Wakebe H; Inoue M; Yamaguchi T; Mitsuhashi S
Antimicrob Agents Chemother; 1991 Dec; 35(12):2562-7. PubMed ID: 1667255
[TBL] [Abstract][Full Text] [Related]
22. In vitro activities of six quinolones and mechanisms of resistance in Staphylococcus aureus and coagulase-negative staphylococci.
Linde HJ; Schmidt M; Fuchs E; Reischl U; Niller HH; Lehn N
Antimicrob Agents Chemother; 2001 May; 45(5):1553-7. PubMed ID: 11302827
[TBL] [Abstract][Full Text] [Related]
23. Mutation in the DNA gyrase A Gene of Escherichia coli that expands the quinolone resistance-determining region.
Friedman SM; Lu T; Drlica K
Antimicrob Agents Chemother; 2001 Aug; 45(8):2378-80. PubMed ID: 11451702
[TBL] [Abstract][Full Text] [Related]
24. Type II topoisomerases as targets for quinolone antibacterials: turning Dr. Jekyll into Mr. Hyde.
Anderson VE; Osheroff N
Curr Pharm Des; 2001 Mar; 7(5):337-53. PubMed ID: 11254893
[TBL] [Abstract][Full Text] [Related]
25. Involvement of an efflux system in high-level fluoroquinolone resistance of Shigella dysenteriae.
Ghosh AS; Ahamed J; Chauhan KK; Kundu M
Biochem Biophys Res Commun; 1998 Jan; 242(1):54-6. PubMed ID: 9439608
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms of action of and resistance to ciprofloxacin.
Hooper DC; Wolfson JS; Ng EY; Swartz MN
Am J Med; 1987 Apr; 82(4A):12-20. PubMed ID: 3034057
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms of resistance to the 4-quinolone antibacterial agents.
Crumplin GC
J Antimicrob Chemother; 1990 Dec; 26 Suppl F():131-44. PubMed ID: 1963425
[TBL] [Abstract][Full Text] [Related]
28. [In vitro activity of new quinolones against clinical strains of Staphylococcus aureus of the wild type and with mutations characterized by gyrA, gyrB and grlA].
Yagüe Guirao G; Martínez-Toldos MC; Alonso Manzanares MA; Gutiérrez Zufiaurre MN; Martínez-Andrés JA; Muñoz Bellido JL; García-Rodríguez JA; Segovia Hernández M
Rev Esp Quimioter; 2000 Sep; 13(3):271-5. PubMed ID: 11086276
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms of action and resistance of older and newer fluoroquinolones.
Hooper DC
Clin Infect Dis; 2000 Aug; 31 Suppl 2():S24-8. PubMed ID: 10984324
[TBL] [Abstract][Full Text] [Related]
30. DNA gyrase and topoisomerase IV on the bacterial chromosome: quinolone-induced DNA cleavage.
Chen CR; Malik M; Snyder M; Drlica K
J Mol Biol; 1996 May; 258(4):627-37. PubMed ID: 8636997
[TBL] [Abstract][Full Text] [Related]
31. [Mechanisms of antimicrobial resistance].
Hori S; Hiramatsu K
Nihon Rinsho; 1994 Feb; 52(2):327-31. PubMed ID: 8126881
[TBL] [Abstract][Full Text] [Related]
32. Mechanisms of quinolone resistance in clinical strains of Pseudomonas aeruginosa.
Jalal S; Wretlind B
Microb Drug Resist; 1998; 4(4):257-61. PubMed ID: 9988043
[TBL] [Abstract][Full Text] [Related]
33. DX-619, a novel des-fluoro(6) quinolone manifesting low frequency of selection of resistant Staphylococcus aureus mutants: quinolone resistance beyond modification of type II topoisomerases.
Strahilevitz J; Truong-Bolduc QC; Hooper DC
Antimicrob Agents Chemother; 2005 Dec; 49(12):5051-7. PubMed ID: 16304172
[TBL] [Abstract][Full Text] [Related]
34. Mode of action of the quinolone antimicrobial agents: review of recent information.
Hooper DC; Wolfson JS
Rev Infect Dis; 1989; 11 Suppl 5():S902-11. PubMed ID: 2549608
[TBL] [Abstract][Full Text] [Related]
35. Reduction of the fitness burden of quinolone resistance in Pseudomonas aeruginosa.
Kugelberg E; Löfmark S; Wretlind B; Andersson DI
J Antimicrob Chemother; 2005 Jan; 55(1):22-30. PubMed ID: 15574475
[TBL] [Abstract][Full Text] [Related]
36. Antibacterial activities of grepafloxacin, ciprofloxacin, ofloxacin and fleroxacin.
Barry AL; Fuchs PC
J Chemother; 1997 Feb; 9(1):9-16. PubMed ID: 9106012
[TBL] [Abstract][Full Text] [Related]
37. [Mechanisms of bacterial resistance to quinolones].
Taléns-Visconti R; Garrigues TM; Cantón E
Rev Esp Quimioter; 2002 Mar; 15(1):25-31. PubMed ID: 12582434
[TBL] [Abstract][Full Text] [Related]
38. In vitro activities of three nonfluorinated quinolones against representative bacterial isolates.
Barry AL; Fuchs PC; Brown SD
Antimicrob Agents Chemother; 2001 Jun; 45(6):1923-7. PubMed ID: 11353655
[TBL] [Abstract][Full Text] [Related]
39. The clinical problems of bacterial resistance to the new quinolones.
Acar JF; Francoual S
J Antimicrob Chemother; 1990 Oct; 26 Suppl B():207-13. PubMed ID: 2175305
[TBL] [Abstract][Full Text] [Related]
40. [Mechanisms of bacterial resistance to quinolones].
Yoshida H
Nihon Saikingaku Zasshi; 1996 Oct; 51(4):973-92. PubMed ID: 8994343
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
